Literature DB >> 18555828

Impact of hormone replacement therapy on exercise training-induced improvements in insulin action in sedentary overweight adults.

Kim M Huffman1, Cris A Slentz, Johanna L Johnson, Gregory P Samsa, Brian D Duscha, Charles J Tanner, Brian H Annex, Joseph A Houmard, William E Kraus.   

Abstract

Exercise training (ET) and hormone replacement therapy (HRT) are both recognized influences on insulin action, but the influence of HRT on responses to ET has not been examined. To determine if HRT use provided additive benefits for the response of insulin action to ET, we evaluated the impact of HRT use on changes in insulin during the course of a randomized, controlled, aerobic ET intervention. Subjects at baseline were sedentary, dyslipidemic, and overweight. These individuals were randomized to 6 months of one of 3 aerobic ET interventions or continued physical inactivity. In 206 subjects, an insulin sensitivity index (S(I)) was obtained with a frequently sampled intravenous glucose tolerance test pre- and post-ET. Baseline and postintervention fitness, regional adiposity, general adiposity, skeletal muscle biochemistry and histology, and serum lipoproteins were measured as other putative mediators influencing insulin action. Two-way analyses of variance were used to determine if sex or HRT use influenced responses to exercise training. Linear modeling was used to determine if predictors for response in S(I) differed by sex or HRT use(.) Women who used HRT (HRT+) demonstrated significantly greater improvements in S(I) with ET than women not using HRT (HRT-). In those HRT+ women, plasma triglyceride change best correlated with change in S(I). For HRT- women, capillary density change and, for men, subcutaneous adiposity change best correlated with change in S(I). In summary, in an ET intervention, HRT use appears to be associated with more robust responses in insulin action. Furthermore, relationships between ET-induced changes in insulin action and potential mediators of change in insulin action are different for men, and for women on or off HRT. These findings have implications for the relative utility of ET for improving insulin action in middle-aged men and women, particularly in the setting of differences in HRT use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18555828      PMCID: PMC2518063          DOI: 10.1016/j.metabol.2008.01.034

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  30 in total

1.  Studies of a targeted risk reduction intervention through defined exercise (STRRIDE).

Authors:  W E Kraus; C E Torgan; B D Duscha; J Norris; S A Brown; F R Cobb; C W Bales; B H Annex; G P Samsa; J A Houmard; C A Slentz
Journal:  Med Sci Sports Exerc       Date:  2001-10       Impact factor: 5.411

2.  Orchestration of glucose homeostasis: from a small acorn to the California oak.

Authors:  Richard N Bergman
Journal:  Diabetes       Date:  2007-06       Impact factor: 9.461

Review 3.  Human body composition: in vivo methods.

Authors:  K J Ellis
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

4.  Effects of the amount and intensity of exercise on plasma lipoproteins.

Authors:  William E Kraus; Joseph A Houmard; Brian D Duscha; Kenneth J Knetzger; Michelle B Wharton; Jennifer S McCartney; Connie W Bales; Sarah Henes; Gregory P Samsa; James D Otvos; Krishnaji R Kulkarni; Cris A Slentz
Journal:  N Engl J Med       Date:  2002-11-07       Impact factor: 91.245

5.  Enhanced muscle insulin receptor autophosphorylation with short-term aerobic exercise training.

Authors:  J F Youngren; S Keen; J L Kulp; C J Tanner; J A Houmard; I D Goldfine
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-03       Impact factor: 4.310

6.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

Review 7.  Invited review: Exercise training-induced changes in insulin signaling in skeletal muscle.

Authors:  Juleen R Zierath
Journal:  J Appl Physiol (1985)       Date:  2002-08

8.  Role of 17beta-estradiol administration on insulin sensitivity in the rat: implications for the insulin receptor.

Authors:  Celestino González; Ana Alonso; Natalia A Grueso; Fernando Díaz; Manuel M Esteban; Serafina Fernández; Angeles M Patterson
Journal:  Steroids       Date:  2002-12       Impact factor: 2.668

9.  Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Authors:  Deborah Grady; David Herrington; Vera Bittner; Roger Blumenthal; Michael Davidson; Mark Hlatky; Judith Hsia; Stephen Hulley; Alan Herd; Steven Khan; L Kristin Newby; David Waters; Eric Vittinghoff; Nanette Wenger
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  3 in total

Review 1.  Toward exercise as personalized medicine.

Authors:  Thomas W Buford; Michael D Roberts; Timothy S Church
Journal:  Sports Med       Date:  2013-03       Impact factor: 11.136

2.  Metabolite signatures of exercise training in human skeletal muscle relate to mitochondrial remodelling and cardiometabolic fitness.

Authors:  Kim M Huffman; Timothy R Koves; Monica J Hubal; Hiba Abouassi; Nina Beri; Lori A Bateman; Robert D Stevens; Olga R Ilkayeva; Eric P Hoffman; Deborah M Muoio; William E Kraus
Journal:  Diabetologia       Date:  2014-08-05       Impact factor: 10.122

3.  Angiotensin (1-7) Expressing Probiotic as a Potential Treatment for Dementia.

Authors:  Abbi R Hernandez; Anisha Banerjee; Christy S Carter; Thomas W Buford
Journal:  Front Aging       Date:  2021-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.